Victoria J. Croog, M.D., Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Croog has expertise in breast cancer, gastrointestinal cancer, gynecologic cancer, brain cancer and tumors of the central nervous system. Dr. Croog earned her medical degree from Harvard Medical School. She completed an internship and a residency in radiation oncology at Memorial Sloan-Kettering Cancer Center. Dr. Croog is involved with several committees at Sibley Memorial Hospital, including the Medical Executive Committee, the IRB/Research Review Committee, the Cancer Committee and the Radiation Safety Committee. She is also a member of the American Society of Clinical Oncology and the American Society of Radiation Oncology. Dr. Croog has been repeatedly named a Top Doctor by Washingtonian Magazine. Dr. Croog has been published in numerous peer-reviewed journals and has presented research at various conferences, such as the American Society of Clinical Oncology’s annual meeting. Make A Gift LinkedIn https://www.linkedin.com/in/victoria-croog-88a31759. Dr. Croog is rated as a Distinguished provider by MediFind in the treatment of Gliosarcoma. Her top areas of expertise are Gliosarcoma, Astrocytoma, Posterior Fossa Tumor, and Endometrial Cancer.

Mateo Ziu is a Neurosurgery specialist and a General Surgeon in Falls Church, Virginia. Dr. Ziu is rated as a Distinguished provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Metastatic Brain Tumor, Glioblastoma, Astrocytoma, Awake Craniotomy, and Laminectomy. Dr. Ziu is currently accepting new patients.

Mark Goldstein is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Goldstein is rated as an Advanced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.

Christina Tsien is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Tsien is rated as an Advanced provider by MediFind in the treatment of Gliosarcoma. Her top areas of expertise are Gliomatosis Cerebri, Glioma, Glioblastoma, Gastrostomy, and Gamma Knife Radiosurgery.

Aminullah Amini is a Neurosurgery provider in Silver Spring, Maryland. Dr. Amini is rated as an Advanced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Subdural Hematoma, Cervical Myelopathy, Normal Pressure Hydrocephalus, Vertebroplasty, and Bone Graft. Dr. Amini is currently accepting new patients.

Yu-hung Kuo is a Neurosurgery provider in Washington, Washington, D.c.. Dr. Kuo is rated as a Distinguished provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Radiation Induced Meningioma, Meningioma, Subdural Hematoma, Awake Craniotomy, and Gastrostomy. Dr. Kuo is currently accepting new patients.

Brett Theeler is a Neurologist in Bethesda, Maryland. Dr. Theeler is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Gliomatosis Cerebri, Glioma, Brain Tumor, and Astrocytoma.

Sam Sater is an Oncologist and a Hematologist in Bethesda, Maryland. Dr. Sater is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Paget Disease of the Breast, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Sater is currently accepting new patients.

Faheem Sandhu is a Neurosurgery provider in Chevy Chase, Maryland. Dr. Sandhu is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Spinal Stenosis, Spondylolisthesis, Epidural Hematoma, Laminectomy, and Cervical Disc Surgery. Dr. Sandhu is currently accepting new patients.

Frederick Barr is a Hematologist Oncology provider in Chevy Chase, Maryland. Dr. Barr is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Urothelial Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Bladder Cancer. Dr. Barr is currently accepting new patients.

Nicholas Farrell is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Farrell is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Lung Cancer, Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, and Iron Deficiency Anemia.

Brandi Page, M.D., is an assistant professor of radiation oncology and molecular sciences for Johns Hopkins Radiation Oncology Department at Suburban Hospital and a radiation oncologist at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Page has expertise in treating all types of cancer and, for the last several years, has become a highly sought-after specialist in the National Capitol Region (NCR-MD/DC/VA) for her expertise in treating head and neck and brain/central nervous system tumors. In Dr. Page's role with Johns Hopkins she has brought new complex radiotherapy services to the facility and facilitated the team building environment for collaborating practitioners and caregivers in the region. Dr. Page also serves on the Cancer Committee for Sibley and Suburban Hospitals for the American Cancer Society, which brings together multidisciplinary care providers to collaborate on initiatives for continued excellence. She is a teaching faculty member at the Johns Hopkins School of Medicine for medical students, residents and fellows, is the current director of radiation oncology fellowships, initiating and growing the first radiation oncology fellowship at the institution a year after the initiation of the proton center. Dr. Page earned her medical degree at Albany Medical College, completed residency in radiation oncology at the Huntsman Cancer Institute at the University of Utah, and fellowship in translational radiation oncology at Wake Forest University Medical Center, where she earned the Service Excellence in Patient Care Award. At Johns Hopkins she has won awards for clinical excellence nominated by peers many years in a row and a Faculty of the Year award for her teaching efforts. Dr. Page is a member of the American Society of Therapeutic Radiation Oncology, a diplomate of the American Board of Radiology, and a Fellow of the American College of Radiation Oncology. Dr. Page has served on the Board of Directors for Radiating Hope and currently serves on the Board of Directors for Courage Unmasked/911-4-HNC (a Head and Neck Cancer support organization). Dr. Page frequently serves as a sought after reviewer for peer reviewed articles and has served as the Continuing Medical Education Editor for the International Journal of Radiation Oncology Biology Physics (IJROBP). Dr. Page believes the best way to empower patients is with knowledge and partnership and she looks forward to partnering with patients in treating their condition, and helping them successfully get through their treatment and maximize opportunities for a happy healthy life after treatment. Make A Gift LinkedIn https://www.linkedin.com/in/brandi-page-968650b0. Dr. Page is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. Her top areas of expertise are Brain Tumor, Throat Cancer, Laryngeal Cancer, Glioma, and Gamma Knife Radiosurgery.

Prior to joining the Mid-Atlantic Epilepsy and Sleep Center, Dr. Jonathan Ross was Director of The New England Epilepsy Institute, a division of New England Neurological Associates (NENA) in Lawrence, Massachusetts. He also served as head of the Neurology division at NENA. After graduating medical school in 1991, Dr. Ross completed postgraduate training at Harvard Medical School and Boston University School of Medicine, and also served as Teaching Fellow at Harvard and Boston University. Dr. Ross is an active member of the American Epilepsy Society, American Clinical Neurophysiology Society, Massachusetts Medical Society, and the American Academy of Neurology. Dr. Ross is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Seizures, Memory Loss, Autosomal Dominant Partial Epilepsy with Auditory Features, and Benign Rolandic Epilepsy.

Shih-Chun (David) Lin, M.D., is a neurosurgeon with Johns Hopkins Neurosurgery in Bethesda, Maryland, as well as an associate professor in the Department of Neurosurgery at the Johns Hopkins University School of Medicine. Dr. Lin offers neurosurgical care to patients with brain or spine diseases. He was the first to introduce several procedures to Suburban Hospital, including endoscopic pituitary surgery, endoscopic extended skull base surgery, minimally invasive spine surgery, neurosurgical complex spinal instrumentation surgery, stereotactic radiosurgery and microvascular decompression for cranial nerve compression syndrome, such as trigeminal neuralgia. He also has clinical expertise in MRI- and CT-guided surgical navigation. Dr. Lin typically treats brain tumors, spinal tumors, pituitary tumors, spinal stenosis, herniated intervertebral disc, skull base tumors, encephalocele, and skull base CSF leak (rhinorrhea or otorrhea). Dr. Lin graduated first place from National Taiwan University College of Medicine, earning his medical degree at the age of 21, the youngest in Taiwan’s history. He then served as a medical/surgical officer in the 206th Infantry Division for the Taiwan Army. He received his Ph.D. in neuroscience from Johns Hopkins University, awarded Phi Beta Kappa and Paul Ehrlich Research Award for his academic and research achievements. Dr. Lin completed his neurosurgical residency at Stanford University Medical Center, where he gained experience in the latest surgical technologies, such as endoscopic surgery, minimally invasive surgery, computer-guided surgical navigation and stereotactic radiosurgery. His research using optogenetics, from his fellowship at Stanford, was awarded by The Congress of Neurological Surgeons. Dr. Lin is a member of the Suburban Hospital Tumor Board. He has worked on several system innovation and quality improvement efforts at Suburban Hospital, such as standardizing critical care protocols for post-operative care for patients undergoing pituitary surgery and establishing MRI protocols for patients implanted with spinal cord stimulators or cardiac pacemakers. Dr. Lin is also a fellow of the American Association of Neurological Surgeons and a member of the Congress of Neurological Surgeons. Dr. Lin has earned numerous awards, such as the Teaching Excellence Award for Stanford University School of Medicine, the Service Excellence Award for Suburban Hospital, Best Consulting Physicians at Johns Hopkins Medicine, Surgeon of the Year Award at Suburban Hospital, and was named one of America's Top Surgeons for Consumers' Research Council of America, Washingtonian Top Doctors, and Bethesda Magazine Top Doctors. Dr. Lin's research interests are in optogenetics, investigating mechanisms behind epilepsy control and glial cell reaction to pathologic conditions. He has contributed to numerous publications and lectures. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Subdural Hematoma, Frontonasal Dysplasia, Binder's Syndrome, Craniectomy, and Awake Craniotomy.

"Dr. Ari D. Fishman is a hematologist affiliated with Sibley Memorial Hospital, Holy Cross Hospital and George Washington University Hospital, where he serves as an assistant professor of medicine for the School of Medicine. He practices out of Maryland Oncology and Hematology, located in Wheaton, Maryland and Silver Spring, Maryland. Dr. Fishman earned his medical degree from Sackler School of Medicine. He completed a residency in internal medicine at the Beth Israel Medical Center, followed by a fellowship in hematology and oncology at the Montefiore Medical Center. Dr. Fishman previously worked at Washington Oncology Hematology Center, located in Washington, D.C. and Chevy Chase, Maryland. Dr. Fishman has been named a Top Doctor in Hematology and Oncology by Washingtonian Magazine and a Top Doctor by Consumers’ Checkbook magazine. Dr. Fishman is a member of the American College of Physicians and the American Society of Clinical Oncology. Dr. Fishman has contributed to numerous publications. Selected Publications Fishman AD, Hoffman A, Volterra F, Frymus M, Gentilluci M. ""Intracaval and intracardiac metastatic nonseminomatous germ cell tumor: a rare cause of hemolytic anemia and thrombocytopenia."" Cancer Invest. 2002;20(7-8):996-1001.". Dr. Fishman is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndrome (MDS), and Childhood Iron Deficiency Anemia.

Alexander Ramos is a Neurologist in Bethesda, Maryland. Dr. Ramos is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Memory Loss, Seizures, Autosomal Dominant Partial Epilepsy with Auditory Features, and Epilepsy.

Dr. Comair is an internationally recognized neurosurgeon and sees patients for a wide range of neurosurgical needs. He offers surgical therapy for diseases of the brain and spine and has pioneered awake craniotomies for the resection of intrinsic brain tumors. His surgical expertise also includes epilepsy surgery, deep brain stimulation for Parkinson’s disease and essential tremor, trigeminal neuralgia surgery, radiosurgery, and treatment for hydrocephalus and herniated disc repair. Dr. Comair received his medical degree from St. Joseph University in Beirut, Lebanon, and completed his neurosurgery residency at Montreal Neurological Institute, McGill University. He completed fellowship training in brain tumor and functional neurosurgery at Montreal Neurological Institute. He has held adjunct faculty appointments at Baylor College of Medicine in Houston, Texas, and the Johns Hopkins University School of Medicine. Dr. Comair has educated scores of neurosurgical trainees in the Middle East, North Africa region, and the U.S., authored more than 120 publications in peer-reviewed journals and two leading textbooks of neurosurgery. He contributed chapters to more than 40 textbooks. Dr. Comair has received multiple awards and recognitions and has been an invited visiting professor to the most prestigious neurosurgery centers. He is a diplomate of the American Board of Neurosurgery and a fellow of the royal college of surgeons of Canada. He serves on the board of directors of the World Society of Functional and Stereotactic Neurosurgery and has been elected to the pediatric epilepsy surgery committee of the International League Against Epilepsy (ILAE). Dr. Comair has held several prominent academic and clinical positions throughout his career, including assistant professor of neurosurgery and head of the pediatric epilepsy surgery section in the Department of Neurosurgery at the UCLA School of Medicine; attending neurosurgeon and head of the section of epilepsy surgery in the Department of Neurosurgery for the Cleveland Clinic Foundation; professor and chair of the Division of Neurosurgery at the American University of Beirut in Lebanon; and professor and vice-chair of the Department of Neurosurgery at Baylor College of Medicine in Houston, Texas. Dr. Comair is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Brain Tumor, Glioma, Oligodendroglioma, Astrocytoma, and Awake Craniotomy.

Dr. Stephen C. Greco is a radiation oncologist at Sibley Memorial Hospital and the director of the department of radiation oncology at Suburban Hospital. Dr. Greco practices out of Sibley’s Prostate Cancer Multidisciplinary Clinic in Washington, D.C. and Suburban Hospital in Bethesda, MD. Dr. Greco has an expertise in various kinds of cancer, including lung, liver, pancreatic and prostate. He has clinical interests in conformal radiation treatment techniques and prostate cancer treatment, including prostate seed implantation. Dr. Greco earned his undergraduate degree from the University of Virginia and his medical degree from Louisiana State University School of Medicine, where he also completed an internship in internal medicine. Dr. Greco completed his residency in radiation oncology at Baylor College of Medicine. Dr. Greco has been named a Top MD by Consumers’ Checkbook Magazine and was named one of the Top Doctors in the Washington D.C., Baltimore and Washington-Baltimore areas by Castle Connolly in 2012. He is a member of the American Society of Clinical Oncology. Dr. Greco has been involved with a clinical trial for “Radiation and Androgen Ablation for Prostate Cancer.” Dr. Greco was also named the 2015 Best Consulting Physician at Suburban Hospital by Johns Hopkins Medicine Clinical Awards for Physicians and Care Teams. Make A Gift Videos 2015 Best Consulting Physician at Suburban Hospital - Stephen Greco, M.D. Dr. Greco is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Prostatectomy.

"Dr. Rachit Kumar is a radiation oncologist specializing in genitourinary and gastrointestinal cancers. He is dedicated to patient-centered care, finding the most effective outcome for each patient and using the latest advances to minimize treatment time and side-effects. Dr. Kumar is frequently published in peer-reviewed journals on new methods of radiation therapy and the benefits to patient outcomes. He is a member of the Johns Hopkins Kimmel Cancer Center and treats patients at both Sibley Memorial Hospital and Suburban Hospital. Selected Publications Kumar R, Tchelebi LT, Anker CJ, Sharma N, Bianchi NA, Dragovic J, Goodman KA, Herman JM, Jiang Y, Jones WE, Kenney TJ, Lee P, Kundranda MK, Russo S, Small W, Suh WW, Yee N, and Jabbour SK. “American Radium Society (ARS) Appropriateness Use Criteria (AUC) for Loco-Regional Gastric Adenocarcinoma: Systemic Review and Guidelines.” American Journal of Clinical Oncology. 2022 Sep 1;45(9):391-402. Rooney MK, Traube B, Khan MK, Kumar R, and Walker GV. “Factors associated with image guided radiation therapy image rejection in a multi-site institution.” JCO Oncology Practice. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, and Kuban DA. “Contemporary Prostate Cancer Treatment Choices in Multidisciplinary Clinics Referenced to National Trends.” Cancer. Tang C, Lei X, Smith GL, Pan HY, Hoffman K, Kumar R, Chapin BF, Shih YC, Frank SJ, and Smith BD. ""Influence of Geography on Prostate Cancer Treatment Coice: An Analysis of the National Medicare Database."" International Journal of Radiation Oncology Biology Physics. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Choi S, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Tu SM, Pilie P, Kovitz C, Kumar R, Roberts T, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn and PG. “Addition of local consolidative therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter randomized phase II basket trial.” JAMA Oncology.". Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, and Prostate Cancer.

Marie Kate Gurka, M.D., is a radiation oncologist in the Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Gurka has expertise in radiation treatment for breast cancer and gynecologic cancers. Dr. Gurka earned her medical degree from Virginia Commonwealth University and completed a residency in radiation oncology at Georgetown University Hospital. She previously served as an instructor in the Department of Radiation Oncology at University of Louisville and has conducted both clinical and basic science research. Her work has been recognized by the American Society for Radiation Oncology (ASTRO), and the American Society of Clinical Oncology (ASCO), and it has been cited in various lectures, research articles, and textbooks. Washingtonian Magazine and Bethesda Magazine have repeatedly named Dr. Gurka a Top Doctor. Selected Publications Oermann EK, Bhandari R, Chen V, Lebec G, Gurka M, Lei S, Chen L, Suy, S, Azumi N, Berkowitz F, Kalhorn C, McGrail K, Collins BT, Jean W, Collins SP. Five Fraction Image-Guided Radiosurgery for Primary and Recurrent Meningiomas. Frontiers in Radiation Oncology. 2013; 3: 213. Gurka MK, Collins SP, Slack R, Tse G, Charabaty A, Ley L, Berzcel L, Lei S, Suy S, Haddad N, Jha R, Johnson CD, Jackson P, Marshall JL, Pishvaian MJ. Stereotactic Body Radiation Therapy with Concurrent Full-Dose Gemcitabine for Locally Advanced Pancreatic Cancer: A Pilot Trial Demonstrating Safety. Radiation Oncology. 2013; 8: 44. Gurka MK, Kim C , Carroll J, Charabaty A, Haddad M, Jackson P, Collins SP, Marshall J, Pishvaian MK, Unger KR. Stereotactic Body Radiation Therapy (SBRT) combined with chemotherapy for unresected pancreatic adenocarcinoma. American Journal of Clinical Oncology. 2014; 152-157. Gurka MK, Horne ZD, Ju A, Chen L, Lei S, Batipps GP, Kowalczyk K, Bandi G, Pahira J, McGeagh KG, Collins BT, Krishnan P, Suy S, Dritschilo A, Lynch JH, Collins SP. Hematuria Following Stereotactic Body Radiation Therapy (SBRT) for Clinically Localized Prostate Cancer. Radiation Oncology. 2015; 10:44. Gurka MK, Pender D, Chuong P, Fouts B, Sebelov A, McNally M, Mezera M, Woo SY, McNally R. Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography. Journal of Controlled Release. 2016; 231:60-67. Dr. Gurka is rated as an Experienced provider by MediFind in the treatment of Gliosarcoma. Her top areas of expertise are Breast Cancer, Intraductal Papilloma, Gliomatosis Cerebri, and Marginal Zone Lymphoma (MZL).